𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Dendritic cell-based immunotherapy for cancer and relevant challenges for transfusion medicine

✍ Scribed by Ching Y Voss; Mark R Albertini; James S Malter


Book ID
113933271
Publisher
Elsevier Science
Year
2004
Tongue
English
Weight
119 KB
Volume
18
Category
Article
ISSN
1532-9496

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Dendritic cell-based immunotherapy for p
✍ Dr. Benjamin A. Tjoa; Dr. Patricia A. Lodge; Dr. Michael L. Salgaller; Dr. Alton πŸ“‚ Article πŸ“… 1999 πŸ› American Cancer Society 🌐 English βš– 167 KB
From pathogen to medicine: HIV-1-derived
✍ Melissa Dullaers; Kris Thielemans πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 272 KB

Over the years, the unique capacity of dendritic cells (DC) for efficient activation of naive T cells has led to their extensive use in cancer immunotherapy protocols. In order to be able to fulfil their role as antigen-presenting cells, the antigen of interest needs to be efficiently introduced and